114 related articles for article (PubMed ID: 9645225)
1. Drug susceptibility of PCA in WBB6F1-W/Wv mice.
Kimura S; Watanabe A; Takeuchi M; Nagata M; Nakamura K; Harada M
Cell Mol Life Sci; 1998 May; 54(5):456-60. PubMed ID: 9645225
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum.
Kimura S; Watanabe A; Takeuchi M; Nagata M; Harada M
Immunol Invest; 1998 Dec; 27(6):379-93. PubMed ID: 9845423
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of drug susceptibility of mouse active anaphylactic shock.
Kimura S; Watanabe A; Nagata M; Niinomi Y; Harada M
Immunol Invest; 1996; 25(5-6):425-34. PubMed ID: 8915680
[TBL] [Abstract][Full Text] [Related]
4. Anti-granulocyte antibody suppression of active and passive anaphylactic shock in WBB6F1-W/Wv mice.
Kimura S; Nagata M; Takeuchi M; Takano K; Harada M
Cell Mol Life Sci; 1997 Aug; 53(8):663-6. PubMed ID: 9351469
[TBL] [Abstract][Full Text] [Related]
5. Active and passive cutaneous anaphylaxis in WBB6F1 mouse, a mast cell-deficient strain.
Arimura A; Nagata M; Takeuchi M; Watanabe A; Nakamura K; Harada M
Immunol Invest; 1990 Jun; 19(3):227-33. PubMed ID: 2365426
[TBL] [Abstract][Full Text] [Related]
6. Production of active and passive anaphylactic shock in the WBB6F1 mouse, a mast cell-deficient strain.
Arimura A; Nagata M; Watanabe A; Nakamura K; Takeuchi M; Harada M
Experientia; 1990 Jul; 46(7):739-42. PubMed ID: 2373200
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice.
Choi IH; Shin YM; Park JS; Lee MS; Han EH; Chai OH; Im SY; Ha TY; Lee HK
J Exp Med; 1998 Nov; 188(9):1587-92. PubMed ID: 9802970
[TBL] [Abstract][Full Text] [Related]
8. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells.
Wershil BK; Mekori YA; Murakami T; Galli SJ
J Immunol; 1987 Oct; 139(8):2605-14. PubMed ID: 3655368
[TBL] [Abstract][Full Text] [Related]
9. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells.
Nakano T; Sonoda T; Hayashi C; Yamatodani A; Kanayama Y; Yamamura T; Asai H; Yonezawa T; Kitamura Y; Galli SJ
J Exp Med; 1985 Sep; 162(3):1025-43. PubMed ID: 3897446
[TBL] [Abstract][Full Text] [Related]
10. PAF-induced airways hyperreactivity is modulated by mast cells in mice.
Longphre M; Zhang LY; Paquette N; Kleeberger SR
Am J Respir Cell Mol Biol; 1996 May; 14(5):461-9. PubMed ID: 8624251
[TBL] [Abstract][Full Text] [Related]
11. Development of large numbers of mast cells at sites of idiopathic chronic dermatitis in genetically mast cell-deficient WBB6F1-W/Wv mice.
Galli SJ; Arizono N; Murakami T; Dvorak AM; Fox JG
Blood; 1987 Jun; 69(6):1661-6. PubMed ID: 3580572
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of 1.5-hour and 48-hour homologous passive cutaneous anaphylaxis in the mouse ear.
Inagaki N; Nagai H; Nakatomi I; Koda A
J Pharmacobiodyn; 1988 Jan; 11(1):31-8. PubMed ID: 2455035
[TBL] [Abstract][Full Text] [Related]
13. Phorbol 12-myristate 13-acetate-induced development of functionally active mast cells in W/Wv but not Sl/Sld genetically mast cell-deficient mice.
Gordon JR; Galli SJ
Blood; 1990 Apr; 75(8):1637-45. PubMed ID: 2328315
[TBL] [Abstract][Full Text] [Related]
14. Immune response potential of mast cell-deficient W/Wv mice.
Ha TY; Reed ND; Crowle PK
Int Arch Allergy Appl Immunol; 1986; 80(1):85-94. PubMed ID: 3514477
[TBL] [Abstract][Full Text] [Related]
15. Mast cells enhance the antibody-mediated injury of skin basement membrane in mice.
Zhang Y; Ramos BF; Jakschik BA
J Immunol; 1992 Oct; 149(7):2482-7. PubMed ID: 1527388
[TBL] [Abstract][Full Text] [Related]
16. Prolonged expulsion of adult Trichinella spiralis and eosinophil infiltration in mast cell-deficient W/Wv mice.
Kamiya M; Oku Y; Itayama H; Ohbayashi M
J Helminthol; 1985 Sep; 59(3):233-9. PubMed ID: 4067246
[TBL] [Abstract][Full Text] [Related]
17. The role of mast cells in thioglycollate-induced inflammation.
Qureshi R; Jakschik BA
J Immunol; 1988 Sep; 141(6):2090-6. PubMed ID: 3171173
[TBL] [Abstract][Full Text] [Related]
18. Higher susceptibility of mast-cell-deficient W/WV mutant mice to brain thromboembolism and mortality caused by intravenous injection of India ink.
Kitamura Y; Taguchi T; Yokoyama M; Inoue M; Yamatodani A; Asano H; Koyama T; Kanamaru A; Hatanaka K; Wershil BK
Am J Pathol; 1986 Mar; 122(3):469-80. PubMed ID: 3513601
[TBL] [Abstract][Full Text] [Related]
19. Topical glucocorticoid augments IgE-mediated passive cutaneous anaphylaxis in Balb/C mice and mast cell deficient WBB6F1 v/v mice.
Katayama I; Igawa K; Minatohara K; Nishioka K
Clin Exp Allergy; 1997 Dec; 27(12):1477-83. PubMed ID: 9433944
[TBL] [Abstract][Full Text] [Related]
20. Deciduoma formation in uterus of genetically mast cell-deficient W/Wv mice.
Hatanaka K; Kitamura Y; Maeyama K; Watanabe T; Matsumoto K
Biol Reprod; 1982 Aug; 27(1):25-8. PubMed ID: 7115851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
